bladder cancer has a very good survival rate. if the cancer is discovered early than the survival rate or five years is 94%. this is very good compared to other cancers we know about today. however when the cancer has spread to the organs in the pelvic region than the rates drop down to 49% and once it has spread to the other organs the rate falls to 6%.
this is a fact that bladder cancer is more common in men then women.- my great-grandfather has this :/
The 5-year survival rate for bladder cancer is around 77% for all stages combined. However, this rate can vary based on factors such as the stage of the cancer at diagnosis, the overall health of the individual, and the type of treatment received. It's important for patients to work closely with their healthcare team to determine the best treatment plan for their specific situation.
Yes, bladder cancer can be life-threatening if it's not diagnosed and treated early. Advanced-stage bladder cancer can spread to other parts of the body and may be more challenging to treat effectively. It's important to seek prompt medical attention if you experience symptoms that could be related to bladder cancer.
Yes, if not treated/ caught early. The prognosis of bladder cancer is poor. It is like any other cancer. Left untreated, it spreads to other parts of the body. If it spreads to the lymphatic system (lymph nodes) it spreads even faster.
The survival rate for prostate cancer varies depending on the stage at diagnosis and individual factors. In general, the 5-year relative survival rate for prostate cancer is close to 100% if detected early. Advanced prostate cancer may have a lower survival rate, often depending on how aggressive the cancer is and how well it responds to treatment.
The bladder stores urine produced by the kidneys, which is a combination of water and waste products. The bladder does not remove water from the body; its primary function is to hold urine until it is expelled from the body during urination.
the urinary bladder is in the midline of the abdomen, behind the pubic bone. the gallbladder is in the upper right abdomen.
Thyroid cancer is generally associated with very high survival rates. The prognosis for thyroid cancer is often favorable, with the majority of patients surviving the disease. Survival rates can vary depending on the specific type and stage of thyroid cancer. Here are some general survival rate statistics: Papillary Thyroid Cancer: Papillary thyroid cancer, the most common type, has a high survival rate. The 5-year relative survival rate for localized papillary thyroid cancer is approximately 99%, meaning that almost all patients with localized disease are alive 5 years after diagnosis. Even for regional (spread to nearby lymph nodes) or distant (metastatic) disease, the 5-year survival rate remains relatively high at around 93%. Follicular Thyroid Cancer: Follicular thyroid cancer also has favorable survival rates. The 5-year relative survival rate for localized disease is approximately 97%. For regional disease, it's about 86%, and for distant disease, it's around 67%. Medullary Thyroid Cancer: Medullary thyroid cancer has slightly lower survival rates compared to papillary and follicular types. For localized disease, the 5-year relative survival rate is around 98%. For regional disease, it's about 89%, and for distant disease, it drops to approximately 41%. Anaplastic Thyroid Cancer: Anaplastic thyroid cancer is the most aggressive form of thyroid cancer, and survival rates are much lower. The 5-year relative survival rate for this type is generally less than 10%, and many cases are fatal.
Colon cancer survival rates vary greatly depending on which stage the cancer is in when diagnosed. On average, a typical 5-year survival rate is between 55% and 63%.
It is possible to survive colon cancer. Cases that are diagnosed early have a much better 5 year survival rate. This is why it is recommended that people get colonoscopies periodically.
Patients who have stage 4 bladder cancer have a low survival rate. The treatment includes chemotherapy, radical cystectomy, external-beam radiation therapy and urinary diversion or cystectomy .
Ovarian cancer can be treated with rounds of chemotherapy. The earlier the treatment, the greater the chance of survival. Stage 1 of the cancer has a 90 percent survival rate, while stage 4 only has a survival rate of 10 percent.
Eighty percent of patients with medullary thyroid cancer will live for at least 10 years after surgery.
The success rate for bladder chemotherapy treatment is getting better, but is still not excellent. The survival rate is about 14 months for advanced cancer cases.
When tumors are in the early stages and have not grown into the bladder wall, they can usually be removed by an outpatient surgical procedure. The five-year survival rate for patients with early stage bladder cancer is 85%. Fortunately, most patients with bladder cancer (up to 80%) will be diagnosed with a superficial tumor. If a tumor has grown into the wall of the bladder but has not spread to other organs, treatment usually involves surgical removal of the tumor, or combined chemotherapy and radiation therapy, with a five-year survival rate of 60%-75%. In more advanced cases, with spread of the cancer to other sites in the body, more aggressive treatment plans must be considered. Per: http://www.medicinenet.com/script/main/art.asp?articlekey=47973
There many advanced methods that are now making prostate cancer's survival rate better. They have advanced drugs to deal with this disease. They also have better chemos and radiation to help kill the cancer cells.
Bladder cancer is cancer affecting the urinary bladder. Bladder cancer is a fairly common form of cancer and men are affected two to three times more than women. Most bladder cancers occur after the age of 55. The disease is not contagious. No one can "catch" bladder cancer from another person.
Do you mean prostate cancer that has spread to the bone? Or survival rates for prostate cancer versus bone cancer? In the case of the former, I believe the prognosis is bad. The highest 10 year survival rates (http://longevity.about.com/od/longevityandillness/a/prostate_le.htm) for prostate treatment is a prostatectomy (surgical prostate removal), but if the cancer has already spread to the bone then prostate removal will not solve the problem, because the cancer has already metastasized. In the case of the latter, there are different demographics and different subtypes of cancer to compare! This, combined with different treatment options, dramatically affects the survival rate.
The survival rate for cervical cancer in the United States is found that 82% of women in the US have a five year survival rate, versus the 73% chance of survival from when in Europe, based on the 2000-02 study by Eurocare, found here: http://www.ncbi.nlm.nih.gov/pubmed/17714993